{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:04:15Z","timestamp":1789110255275,"version":"build-2803163510"},"reference-count":115,"publisher":"Portland Press Ltd.","issue":"16","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:p>Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, including in the United States. Risk factors such as high cholesterol, diabetes, obesity, smoking, physical inactivity, and hypertension contribute significantly to their development. Emerging evidence highlights a central role for chemokines\u2014small signaling molecules that guide immune cell migration to sites of infection, inflammation, or tissue damage\u2014in the initiation and progression of hypertension. This positions chemokines and their receptors as promising pharmacological targets for blood pressure regulation and vascular protection. In this review, we explore the therapeutic potential of targeting chemokines and their receptors and summarize the main strategies reported in the literature for managing hypertension through these pathways. For this purpose, an analysis of drugs that act on the most relevant receptors at the preclinical and clinical levels was performed. After this analysis, their mechanisms of action, selectivity, and possible adverse effects were discussed. In conclusion, we reinforce that the modulation of chemokines and their receptors represents a promising approach in the control of CVDs, especially hypertension, although further clinical studies are needed to validate the efficacy and safety of this strategy, considering possible impacts on other essential immune responses.<\/jats:p>","DOI":"10.1042\/cs20257214","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:51:35Z","timestamp":1756468295000},"page":"880-895","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension"],"prefix":"10.1042","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-2131","authenticated-orcid":false,"given":"Luis Henrique","family":"Oliveira de Moraes","sequence":"first","affiliation":[{"name":"1Physiological Sciences, Universidade Federal de S\u00e3o Carlos, S\u00e3o Carlos, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Beling","sequence":"additional","affiliation":[{"name":"2Physiology and Cell Biology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6390-3803","authenticated-orcid":false,"given":"Gustavo","family":"Felix Pimenta","sequence":"additional","affiliation":[{"name":"2Physiology and Cell Biology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL, U.S.A"},{"name":"3Department of Pharmacology, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5671-318X","authenticated-orcid":false,"given":"Thiago","family":"Bruder-Nascimento","sequence":"additional","affiliation":[{"name":"2Physiology and Cell Biology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2025082907512413200_CS-2025-7214C1","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the american heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"2025082907512413200_CS-2025-7214C2","volume-title":"Sabate\u0301 E. Adherence to Long-Term Therapies: Evidence for Action","author":"World Health Organization","year":"2003"},{"key":"2025082907512413200_CS-2025-7214C3","unstructured":"WHO\n          . Hypertension: WORLD HEALTH ORGANIZATION (WHO). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension"},{"key":"2025082907512413200_CS-2025-7214C4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2025082907512413200_CS-2025-7214C5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"2025082907512413200_CS-2025-7214C6","doi-asserted-by":"crossref","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: Function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol"},{"key":"2025082907512413200_CS-2025-7214C7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.123.21888","article-title":"Role of the CCL5 and Its Receptor, CCR5, in the genesis of aldosterone-induced hypertension, vascular dysfunction, and end-organ damage","volume":"81","author":"Costa","year":"2024","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"2025082907512413200_CS-2025-7214C9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173224","article-title":"Chemokine binding protein \u201cM3\u201d limits atherosclerosis in apolipoprotein E-\/- mice","volume":"12","author":"Ravindran","year":"2017","journal-title":"PLoS ONE"},{"key":"2025082907512413200_CS-2025-7214C10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/jbcpp-2020-0523","article-title":"Chemokine receptor antagonists with alpha(1)-adrenergic receptor blocker activity","volume":"33","author":"DeSantis","year":"2021","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C11","doi-asserted-by":"crossref","first-page":"114859","DOI":"10.1016\/j.bcp.2021.114859","article-title":"CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1","volume":"195","author":"Singh","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3109\/14653240903131640","article-title":"Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease","volume":"11","author":"Blum","year":"2009","journal-title":"Cytotherapy"},{"key":"2025082907512413200_CS-2025-7214C13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2016.05.028","article-title":"Plerixafor improves the endothelial health balance. the effect of diabetes analysed by polychromatic flow cytometry","volume":"251","author":"Cappellari","year":"2016","journal-title":"Atherosclerosis"},{"key":"2025082907512413200_CS-2025-7214C14","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.clinthera.2019.07.015","article-title":"Colchicine as a novel therapy for suppressing chemokine production in patients with an acute coronary syndrome: a pilot study","volume":"41","author":"Tucker","year":"2019","journal-title":"Clin. Ther."},{"key":"2025082907512413200_CS-2025-7214C15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.STR.26.4.661","article-title":"Monocyte chemoattractant protein\u20131 Messenger RNA expression in rat ischemic cortex","volume":"26","author":"Wang","year":"1995","journal-title":"Stroke"},{"key":"2025082907512413200_CS-2025-7214C16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.HYP.30.6.1397","article-title":"Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats","volume":"30","author":"Capers","year":"1997","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C17","first-page":"1194","article-title":"RANTES chemokine expression in transplant-associated accelerated atherosclerosis","volume":"15","author":"Pattison","year":"1996","journal-title":"J. Heart Lung Transplant."},{"key":"2025082907512413200_CS-2025-7214C18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"2025082907512413200_CS-2025-7214C19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2017.02.026","article-title":"The role of chemokines in hypertension and consequent target organ damage","volume":"119","author":"Rudemiller","year":"2017","journal-title":"Pharmacol. Res"},{"key":"2025082907512413200_CS-2025-7214C20","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1161\/ATVBAHA.119.312580","article-title":"Endothelial response to pathophysiological stress","volume":"39","author":"Peng","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025082907512413200_CS-2025-7214C21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00188","article-title":"Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest","volume":"3","author":"Dixit","year":"2012","journal-title":"Front. Immunol."},{"key":"2025082907512413200_CS-2025-7214C22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2025082907512413200_CS-2025-7214C23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/2175-8239-jbn-2021-0030","article-title":"Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients","volume":"44","author":"Schettini","year":"2022","journal-title":"J. Bras. Nefrol."},{"key":"2025082907512413200_CS-2025-7214C24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40620-017-0452-4","article-title":"Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury","volume":"31","author":"Fani","year":"2018","journal-title":"J. Nephrol."},{"key":"2025082907512413200_CS-2025-7214C25","first-page":"564","author":"Abbas","year":"2005"},{"key":"2025082907512413200_CS-2025-7214C26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2008.04.022","article-title":"Chemokines and neuromodulation","volume":"198","author":"M\u00e9lik-Parsadaniantz","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"2025082907512413200_CS-2025-7214C27","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1074\/jbc.275.8.5466","article-title":"Human vascular smooth muscle cells possess functional CCR5","volume":"275","author":"Schecter","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"2025082907512413200_CS-2025-7214C28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2002-05-1480","article-title":"Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion","volume":"103","author":"Haque","year":"2004","journal-title":"Blood"},{"key":"2025082907512413200_CS-2025-7214C29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease","volume":"11","author":"Wong","year":"2002","journal-title":"Cardiovasc. Pathol."},{"key":"2025082907512413200_CS-2025-7214C30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2249.2003.02323.x","article-title":"Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration","volume":"134","author":"Hillyer","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"2025082907512413200_CS-2025-7214C31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063182","article-title":"Endothelial autocrine signaling through CXCL12\/CXCR4\/FoxM1 axis contributes to severe pulmonary arterial hypertension","volume":"22","author":"Yi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2025082907512413200_CS-2025-7214C32","doi-asserted-by":"crossref","first-page":"107799","DOI":"10.1016\/j.pharmthera.2020.107799","article-title":"Role of inflammatory chemokines in hypertension","volume":"223","author":"Mikolajczyk","year":"2021","journal-title":"Pharmacol. Ther"},{"key":"2025082907512413200_CS-2025-7214C33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"2025082907512413200_CS-2025-7214C34","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"2025082907512413200_CS-2025-7214C35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00952","article-title":"Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy","volume":"11","author":"Morein","year":"2020","journal-title":"Front. Immunol."},{"key":"2025082907512413200_CS-2025-7214C36","first-page":"359","article-title":"Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses","volume":"10","author":"Salcedo","year":"2003","journal-title":"Microcirculation"},{"key":"2025082907512413200_CS-2025-7214C37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060971","article-title":"New insights into mechanisms and functions of chemokine (C-X-C Motif) Receptor 4 heteromerization in vascular smooth muscle","volume":"17","author":"Evans","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"2025082907512413200_CS-2025-7214C38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/01.ATV.18.3.397","article-title":"Human vascular smooth muscle cells express receptors for cc chemokines","volume":"18","author":"Hayes","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025082907512413200_CS-2025-7214C39","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00005344-198900146-00012","article-title":"Receptor-operated calcium-permeable channels in vascular smooth muscle","volume":"14 Suppl 6","author":"R\u00fcegg","year":"1989","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2008.183","article-title":"The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease","volume":"74","author":"Eardley","year":"2008","journal-title":"Kidney Int."},{"key":"2025082907512413200_CS-2025-7214C41","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025082907512413200_CS-2025-7214C42","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ki.2008.500","article-title":"The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia\u2013reperfusion injury","volume":"74","author":"Li","year":"2008","journal-title":"Kidney Int."},{"key":"2025082907512413200_CS-2025-7214C43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamacardio.2020.5392","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with cardiovascular mortality: a meta-analysis of population-based studies","volume":"6","author":"Georgakis","year":"2021","journal-title":"JAMA Cardiol."},{"key":"2025082907512413200_CS-2025-7214C44","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2025082907512413200_CS-2025-7214C45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.HYP.36.3.360","article-title":"CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension","volume":"36","author":"Bush","year":"2000","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C46","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1002\/jcp.30375","article-title":"The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases","volume":"236","author":"Zhu","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"2025082907512413200_CS-2025-7214C47","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front. Immunol."},{"key":"2025082907512413200_CS-2025-7214C48","first-page":"1458","article-title":"Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats","volume":"13","author":"Xu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"2025082907512413200_CS-2025-7214C49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"2025082907512413200_CS-2025-7214C50","doi-asserted-by":"crossref","first-page":"119034","DOI":"10.1016\/j.lfs.2021.119034","article-title":"Role of CCL2\/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches","volume":"269","author":"Moadab","year":"2021","journal-title":"Life Sci. (1962)"},{"key":"2025082907512413200_CS-2025-7214C51","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"key":"2025082907512413200_CS-2025-7214C52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1142\/S0192415X22500082","article-title":"Effects of crocin on ccl2\/ccr2 inflammatory pathway in monocrotaline-induced pulmonary arterial hypertension rats","volume":"50","author":"Sheng","year":"2022","journal-title":"Am. J. Chin. Med. (Gard City N Y)"},{"key":"2025082907512413200_CS-2025-7214C53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.RES.83.9.952","article-title":"Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells","volume":"83","author":"Chen","year":"1998","journal-title":"Circ. Res."},{"key":"2025082907512413200_CS-2025-7214C54","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.RES.0000126924.23467.A3","article-title":"Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling","volume":"94","author":"Ishibashi","year":"2004","journal-title":"Circ. Res."},{"key":"2025082907512413200_CS-2025-7214C55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10439-009-9684-3","article-title":"High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells","volume":"37","author":"Li","year":"2009","journal-title":"Ann. Biomed. Eng."},{"key":"2025082907512413200_CS-2025-7214C56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(00)90084-8","article-title":"Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells","volume":"105","author":"Molet","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025082907512413200_CS-2025-7214C57","first-page":"1307","article-title":"Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia","volume":"24","author":"Tucci","year":"2006","journal-title":"J Hypertens (Los Angel)"},{"key":"2025082907512413200_CS-2025-7214C58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: from AIDS to atherosclerosis","volume":"162","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis."},{"key":"2025082907512413200_CS-2025-7214C60","article-title":"Chemokine receptor 5, a double-edged sword in metabolic syndrome and cardiovascular disease","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006387","article-title":"C-C Chemokine receptor type 5 (ccr5)-mediated docking of transferred tregs protects against early blood-brain barrier disruption after stroke","volume":"6","author":"Li","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"2025082907512413200_CS-2025-7214C62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/HYPERTENSIONAHA.120.14698","article-title":"Chemokine receptor CXCR-2 initiates atrial fibrillation by triggering monocyte mobilization in mice","volume":"76","author":"Zhang","year":"2020","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.12659\/MSM.897307","article-title":"PPAR-\u03b1 agonist fenofibrate decreased RANTES Levels in type 2 diabetes patients with hypertriglyceridemia","volume":"22","author":"Feng","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"2025082907512413200_CS-2025-7214C64","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.prp.2014.03.012","article-title":"Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis","volume":"210","author":"Lv","year":"2014","journal-title":"Pathol. Res. Pract"},{"key":"2025082907512413200_CS-2025-7214C65","first-page":"321","article-title":"Chemokine RANTES is increased at early stages of coronary artery disease","volume":"67","author":"Podolec","year":"2016","journal-title":"J. Physiol. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C66","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1096\/fj.201500088R","article-title":"Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension","volume":"30","author":"Mikolajczyk","year":"2016","journal-title":"FASEB J."},{"key":"2025082907512413200_CS-2025-7214C67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.ATV.0000253886.44609.ae","article-title":"Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice","volume":"27","author":"Braunersreuther","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025082907512413200_CS-2025-7214C68","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2005-09-3922","article-title":"Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10","volume":"107","author":"Zernecke","year":"2006","journal-title":"Blood"},{"key":"2025082907512413200_CS-2025-7214C69","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"2025082907512413200_CS-2025-7214C70","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018074","article-title":"HIV Protease inhibitor ritonavir impairs endothelial function via reduction in adipose mass and endothelial leptin receptor-dependent increases in NADPH Oxidase 1 (Nox1), C-C chemokine receptor Type 5 (CCR5), and Inflammation","volume":"9","author":"Bruder-Nascimento","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"2025082907512413200_CS-2025-7214C71","doi-asserted-by":"crossref","first-page":"155238","DOI":"10.1016\/j.phymed.2023.155238","article-title":"Ginsenoside Rg1 treats ischemic stroke by regulating CKLF1\/CCR5 axis-induced neuronal cell pyroptosis","volume":"123","author":"Long","year":"2024","journal-title":"Phytomedicine"},{"key":"2025082907512413200_CS-2025-7214C72","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ajh.2011.243","article-title":"CCR5 deficiency does not reduce hypertensive end-organ damage in mice","volume":"25","author":"Krebs","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"2025082907512413200_CS-2025-7214C73","article-title":"The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)","volume":"15","author":"Korbecki","journal-title":"Cancers (Basel)"},{"key":"2025082907512413200_CS-2025-7214C74","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"2025082907512413200_CS-2025-7214C75","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2353\/ajpath.2006.040748","article-title":"Up-regulated expression of the CXCR2 ligand KC\/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression","volume":"168","author":"Boisvert","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2025082907512413200_CS-2025-7214C76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"key":"2025082907512413200_CS-2025-7214C77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"2025082907512413200_CS-2025-7214C78","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.106.660472","article-title":"Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice","volume":"115","author":"Bot","year":"2007","journal-title":"Circulation"},{"key":"2025082907512413200_CS-2025-7214C79","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/ATVBAHA.110.220202","article-title":"Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-\/- mice","volume":"31","author":"Wu","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025082907512413200_CS-2025-7214C80","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1523-1747.2000.00034.x","article-title":"Delayed wound healing in CXCR2 knockout mice","volume":"115","author":"Devalaraja","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"2025082907512413200_CS-2025-7214C81","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","article-title":"The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity","volume":"165","author":"Addison","year":"2000","journal-title":"J. Immunol."},{"key":"2025082907512413200_CS-2025-7214C82","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","article-title":"Chemokines in vascular dysfunction and remodeling","volume":"28","author":"Schober","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025082907512413200_CS-2025-7214C83","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"2025082907512413200_CS-2025-7214C84","doi-asserted-by":"crossref","first-page":"165551","DOI":"10.1016\/j.bbadis.2019.165551","article-title":"Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats","volume":"1865","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis"},{"key":"2025082907512413200_CS-2025-7214C85","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"key":"2025082907512413200_CS-2025-7214C86","article-title":"Kr\u00fcppel-Like Factor 15 Modulates CXCL1\/CXCR2 Signaling-mediated inflammatory response contributing to angiotensin ii-induced cardiac remodeling","volume":"9","author":"He","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"2025082907512413200_CS-2025-7214C87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s12975-024-01304-2","article-title":"Blockade of the platelet-driven CXCL7-CXCR1\/2 inflammatory axis prevents murine cerebral aneurysm formation and rupture","volume":"16","author":"Nowicki","year":"2025","journal-title":"Transl. Stroke Res."},{"key":"2025082907512413200_CS-2025-7214C88","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"2025082907512413200_CS-2025-7214C89","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur. Heart J."},{"key":"2025082907512413200_CS-2025-7214C90","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.7150\/ijbs.65802","article-title":"CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"2025082907512413200_CS-2025-7214C91","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCHEARTFAILURE.110.960831","article-title":"CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess","volume":"4","author":"Chu","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"2025082907512413200_CS-2025-7214C92","first-page":"29","article-title":"Role of chemokine receptor 2 in renal damage induced by deoxycorticosterone acetate-salt hypertension","volume":"35","author":"Sun","year":"2013","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"2025082907512413200_CS-2025-7214C93","first-page":"488","article-title":"Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype","volume":"36","author":"Zhu","year":"2014","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"2025082907512413200_CS-2025-7214C94","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/1535370214565970","article-title":"Role of the monocyte chemoattractant protein-1\/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension","volume":"240","author":"Wang","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2025082907512413200_CS-2025-7214C95","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.112.201251","article-title":"Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone\/salt-treated mice","volume":"60","author":"Chan","year":"2012","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C96","doi-asserted-by":"crossref","first-page":"H906","DOI":"10.1152\/ajpheart.00821.2014","article-title":"M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure","volume":"309","author":"Moore","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2025082907512413200_CS-2025-7214C97","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2125.2009.03503.x","article-title":"Maraviroc and raltegravir","volume":"68","author":"Dubois","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.121.17712","article-title":"Neutrophil gelatinase-associated lipocalin from macrophages plays a critical role in renal fibrosis Via the CCL5 (Chemokine Ligand 5)-Th2 Cells-IL4 (Interleukin 4) Pathway","volume":"79","author":"Bonnard","year":"2022","journal-title":"Hypertension"},{"key":"2025082907512413200_CS-2025-7214C99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1248\/bpb.34.120","article-title":"Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats","volume":"34","author":"Kim","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"2025082907512413200_CS-2025-7214C100","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1158\/1078-0432.CCR-16-2748","article-title":"Phase ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-Negative Metastatic Breast Cancer","volume":"23","author":"Schott","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"2025082907512413200_CS-2025-7214C101","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1165\/rcmb.2017-0214OC","article-title":"Myeloid-derived suppressor cells are necessary for development of pulmonary hypertension","volume":"58","author":"Bryant","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2025082907512413200_CS-2025-7214C102","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1111\/jcmm.15694","article-title":"Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"2025082907512413200_CS-2025-7214C103","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"2025082907512413200_CS-2025-7214C104","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/CIRCRESAHA.109.197533","article-title":"Inhibition of the SDF-1\/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension","volume":"104","author":"Young","year":"2009","journal-title":"Circ. Res."},{"key":"2025082907512413200_CS-2025-7214C105","doi-asserted-by":"crossref","first-page":"115047","DOI":"10.1016\/j.bcp.2022.115047","article-title":"Activation of CXCL13\/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome","volume":"200","author":"Zhao","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C106","doi-asserted-by":"crossref","first-page":"167084","DOI":"10.1016\/j.bbadis.2024.167084","article-title":"HIV and gp120-induced lipid droplets loss in hepatic stellate cells contribute to profibrotic profile","volume":"1870","author":"L\u00f3pez","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis"},{"key":"2025082907512413200_CS-2025-7214C107","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/ndt\/gfs360","article-title":"The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion","volume":"27","author":"Tsutahara","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"2025082907512413200_CS-2025-7214C108","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1351655","article-title":"CCR5\/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome","volume":"15","author":"Chernov","year":"2024","journal-title":"Front. Pharmacol."},{"key":"2025082907512413200_CS-2025-7214C109","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2025082907512413200_CS-2025-7214C110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.0300-9475.2004.01399.x","article-title":"Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response","volume":"59","author":"S\u00f8rensen","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"2025082907512413200_CS-2025-7214C111","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molimm.2012.03.022","article-title":"Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888","volume":"51","author":"Obmolova","year":"2012","journal-title":"Mol. Immunol."},{"key":"2025082907512413200_CS-2025-7214C112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11523-014-0320-2","article-title":"Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study","volume":"10","author":"Brana","year":"2015","journal-title":"Target. Oncol."},{"key":"2025082907512413200_CS-2025-7214C113","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1183\/13993003.01558-2014","article-title":"CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir. J."},{"key":"2025082907512413200_CS-2025-7214C114","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"2025082907512413200_CS-2025-7214C115","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/139\/16\/880\/976957\/cs-2025-7214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/139\/16\/880\/976957\/cs-2025-7214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:51:47Z","timestamp":1756468307000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/139\/16\/880\/236429\/Chemokine-receptors-in-vascular-biology-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":115,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20257214","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8]]}}}